Mode
Text Size
Log in / Sign up

AZD7442

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of AZD7442

6 trials tracked of AZD7442: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 663 citations.

6Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 4 Phase 1 2
  1. Phase 3 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. Completed · 663 cited
  2. Phase 3 Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults Completed · 226 cited
  3. Phase 3 Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults Completed · 152 cited
  4. Phase 3 AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) Completed · 127 cited
  5. Phase 1 Study to Evaluate Pharmacokinetic Comparability Between AZD7442 Co-formulation (AZD8895 + AZD1061) vs AZD8895 and AZD1061 Individually in Adult Healthy Participants Completed
  6. Phase 1 AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.